Related Experiment Video
Updated: Aug 29, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Correlates of antiretroviral treatment breaks
J G Grierson1, S A Misson, M K Pitts
1Australian Research Centre in Sex, Health & Society, La Trobe University, Melbourne, Australia. j.grierson@latrobe.edu.au
Objective:
To identify key relationships between the decision to take a break from antiretroviral treatments and potential clinical and social antecedents.
Methods:
An analysis of a self-completed survey of various clinical and social aspects of the lives of people living with HIV/AIDS (PLWHA) distributed nationally in Australia was carried out.
Results:
The questionnaire was completed by a sample of 894 PLWHA. From this sample, three groups of interest were identified: a 'no break' group that had been using antiretrovirals continuously (n=378), a 'lifestyle break' group that had taken a break for purely lifestyle reasons on their last occasion (n=76), and a 'clinical break' group that had taken a break for purely clinical reasons on their last occasion (n=99). Clinical breaks were found to be longer than lifestyle breaks and involved more consultation with doctors. Differences were also found between the two break types in effects on the respondents' health and well-being. The clinical break group was further found to experience a higher level of health difficulties on a range of variables, while the lifestyle break group was younger, had a longer experience of HIV and its consequences, and engaged in greater participation in activities associated with both pleasure and risk.
Conclusions:
The analyses offer a pattern of health and social factors that places the HIV-positive individual, as a social actor, squarely within the experience of treatment interruptions. Understanding the social motivations and correlates of treatment interruption offers new challenges in maximizing the efficacy of health maintenance and support for PLWHA.
Related Concept Videos
Retrovirus Life Cycles
Therapeutic Drug Monitoring: Affecting Factors
Antiviral Nucleoside Inhibitors
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Inhibitors of Virion Maturation and Assembly
Subviral Agents

